Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: After-Hours Movers » 18:51
05/18/21
05/18
18:51
05/18/21
18:51
TCOM

Trip.com Group

$39.41 /

+0.49 (+1.26%)

, IBEX

Ibex

$22.45 /

-0.04 (-0.18%)

, TTWO

Take-Two

$167.78 /

-0.36 (-0.21%)

, AGTI

Agiliti

$15.17 /

+0.41 (+2.78%)

, TCS

Container Store

$13.11 /

-0.15 (-1.13%)

, STE

Steris

$195.90 /

-0.63 (-0.32%)

, IOVA

Iovance Biotherapeutics

$26.97 /

+0.48 (+1.81%)

, PRPL

Purple Innovation

$32.38 /

+0.43 (+1.35%)

, TLRY

Tilray

$15.57 /

+0.42 (+2.77%)

Check out this evening's…

ShowHide Related Items >><<
TTWO Take-Two
$167.78 /

-0.36 (-0.21%)

TLRY Tilray
$15.57 /

+0.42 (+2.77%)

TCS Container Store
$13.11 /

-0.15 (-1.13%)

STE Steris
$195.90 /

-0.63 (-0.32%)

PRPL Purple Innovation
$32.38 /

+0.43 (+1.35%)

IOVA Iovance Biotherapeutics
$26.97 /

+0.48 (+1.81%)

IBEX Ibex
$22.45 /

-0.04 (-0.18%)

TCOM Trip.com Group
$39.41 /

+0.49 (+1.26%)

05/17/21
Fly Intel: Top five analyst upgrades
05/17/21 Morgan Stanley
Morgan Stanley upgrades Trip.com to Overweight on travel rebound
05/17/21 Morgan Stanley
Trip.com Group upgraded to Overweight from Equal Weight at Morgan Stanley
04/19/21 Goldman Sachs
Trip.com Group upgraded to Buy on recovery prospects at Goldman Sachs
IBEX Ibex
$22.45 /

-0.04 (-0.18%)

11/23/20 Citi
Ibex price target raised to $22 from $18 at Citi
09/25/20 Citi
Ibex price target lowered to $18 from $22 at Citi
09/11/20 Piper Sandler
Ibex selloff brings valuation 'disconnect,' says Piper Sandler
09/01/20 Truist
Ibex initiated with a Buy at Truist
TTWO Take-Two
$167.78 /

-0.36 (-0.21%)

04/28/21 MKM Partners
Take-Two price target lowered to $185 from $205 at MKM Partners
04/22/21 Jefferies
Take-Two assumed with a Hold at Jefferies
03/16/21 KeyBanc
Partnership with Tiger Woods 'incremental positive' for Take-Two, says KeyBanc
02/09/21 Wells Fargo
Take-Two price target raised to $235 from $205 at Wells Fargo
AGTI Agiliti
$15.17 /

+0.41 (+2.78%)

09:55 Today
Fly Intel: Top five analyst initiations
08:10 Today Jefferies
Jefferies starts medical equipment outsourcing 'pioneer' Agiliti at Buy
07:31 Today KeyBanc
KeyBanc bullish on Agiliti, initiates with an Overweight
07:24 Today UBS
Agiliti initiated with a Neutral at UBS
TCS Container Store
$13.11 /

-0.15 (-1.13%)

11/09/20 Goldman Sachs
Container Store upgraded to Neutral from Sell at Goldman Sachs
08/04/20
Fly Intel: Top five analyst downgrades
08/04/20 Goldman Sachs
Container Store downgraded to Sell from Neutral at Goldman Sachs
STE Steris
$195.90 /

-0.63 (-0.32%)

05/11/21 JMP Securities
Steris price target raised to $235 from $217 at JMP Securities
02/04/21
Fly Intel: Top five analyst upgrades
02/04/21 KeyBanc
Steris upgraded to Overweight at KeyBanc
02/03/21 KeyBanc
Steris upgraded to Overweight from Sector Weight at KeyBanc
IOVA Iovance Biotherapeutics
$26.97 /

+0.48 (+1.81%)

05/05/21 Wells Fargo
Wells sees 'limited impact' on Iovance's lifileucel from Keytruda/Yervoy data
05/03/21 Truist
Iovance Biotherapeutics initiated with a Buy at Truist
05/03/21 Truist
Iovance Biotherapeutics initiated with a Buy at Truist
04/16/21 Goldman Sachs
Iovance Biotherapeutics initiated with a Buy at Goldman Sachs
PRPL Purple Innovation
$32.38 /

+0.43 (+1.35%)

07:50 Today Wedbush
Purple Innovation price target raised to $37 from $32 at Wedbush
04/20/21 B. Riley
Purple Innovation price target raised to $38 from $33 at B. Riley
03/05/21 B. Riley
Purple Innovation selloff 'attractive buying opportunity,' says B. Riley
03/05/21 Wedbush
Purple Innovation price target lowered to $32 from $38 at Wedbush
TLRY Tilray
$15.57 /

+0.42 (+2.77%)

05/11/21 Cowen
Tilray resumed with Outperform at Cowen
05/11/21 Cowen
Tilray resumed with an Outperform at Cowen
05/07/21
Fly Intel: Top five analyst upgrades
05/07/21 Jefferies
Jefferies double upgrades Tilray to Buy on 'perfect match' merger
TTWO Take-Two
$167.78 /

-0.36 (-0.21%)

TLRY Tilray
$15.57 /

+0.42 (+2.77%)

TCS Container Store
$13.11 /

-0.15 (-1.13%)

TCOM Trip.com Group
$39.41 /

+0.49 (+1.26%)

STE Steris
$195.90 /

-0.63 (-0.32%)

PRPL Purple Innovation
$32.38 /

+0.43 (+1.35%)

IOVA Iovance Biotherapeutics
$26.97 /

+0.48 (+1.81%)

IBEX Ibex
$22.45 /

-0.04 (-0.18%)

AGTI Agiliti
$15.17 /

+0.41 (+2.78%)

  • 19
    May
  • 23
    Apr
  • 10
    Sep
  • 07
    Aug
  • 29
    May
TTWO Take-Two
$167.78 /

-0.36 (-0.21%)

TLRY Tilray
$15.57 /

+0.42 (+2.77%)

STE Steris
$195.90 /

-0.63 (-0.32%)

TTWO Take-Two
$167.78 /

-0.36 (-0.21%)

TLRY Tilray
$15.57 /

+0.42 (+2.77%)

TCS Container Store
$13.11 /

-0.15 (-1.13%)

TCOM Trip.com Group
$39.41 /

+0.49 (+1.26%)

STE Steris
$195.90 /

-0.63 (-0.32%)

IBEX Ibex
$22.45 /

-0.04 (-0.18%)

TTWO Take-Two
$167.78 /

-0.36 (-0.21%)

TLRY Tilray
$15.57 /

+0.42 (+2.77%)

TCS Container Store
$13.11 /

-0.15 (-1.13%)

TCOM Trip.com Group
$39.41 /

+0.49 (+1.26%)

PRPL Purple Innovation
$32.38 /

+0.43 (+1.35%)

Earnings
Agiliti sees FY21 revenue $950M-$975M » 16:22
05/18/21
05/18
16:22
05/18/21
16:22
AGTI

Agiliti

$15.17 /

+0.41 (+2.78%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGTI Agiliti
$15.17 /

+0.41 (+2.78%)

09:55 Today
Fly Intel: Top five analyst initiations
08:10 Today Jefferies
Jefferies starts medical equipment outsourcing 'pioneer' Agiliti at Buy
07:31 Today KeyBanc
KeyBanc bullish on Agiliti, initiates with an Overweight
07:24 Today UBS
Agiliti initiated with a Neutral at UBS
AGTI Agiliti
$15.17 /

+0.41 (+2.78%)

  • 23
    Apr
Earnings
Agiliti reports Q1 EPS 30c vs. 5c last year » 16:21
05/18/21
05/18
16:21
05/18/21
16:21
AGTI

Agiliti

$15.17 /

+0.41 (+2.78%)

Reports Q1 revenue $235M,…

Reports Q1 revenue $235M, up 31% from last year. "Our strong first quarter results reflect the continued execution of our growth strategy and the extraordinary work of our entire team at Agiliti," said Tom Leonard, CEO. "The challenges of the past year helped raise awareness of the unique and essential nature of what we do, while also demonstrating the stable and predictable nature of our business model. Agiliti is a critical part of our national healthcare infrastructure, and as the events of 2020 highlight, the services we provide are always necessary and in high demand. This long term consistency gives us confidence in our 2021 outlook and beyond."

ShowHide Related Items >><<
AGTI Agiliti
$15.17 /

+0.41 (+2.78%)

09:55 Today
Fly Intel: Top five analyst initiations
08:10 Today Jefferies
Jefferies starts medical equipment outsourcing 'pioneer' Agiliti at Buy
07:31 Today KeyBanc
KeyBanc bullish on Agiliti, initiates with an Overweight
07:24 Today UBS
Agiliti initiated with a Neutral at UBS
  • 23
    Apr
Initiation
Fly Intel: Top five analyst initiations » 09:55
05/18/21
05/18
09:55
05/18/21
09:55
RAIN

Rain Therapeutics

$16.72 /

+0.415 (+2.55%)

, SWIM

Latham Group

$33.08 /

+0.39 (+1.19%)

, POOL

Pool Corp.

$436.99 /

+0.98 (+0.22%)

, BNTX

BioNTech

$193.16 /

-5.01 (-2.53%)

, AGTI

Agiliti

$15.04 /

+0.28 (+1.90%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Rain Therapeutics (RAIN) initiated with an Overweight at Piper Sandler and initiated with a Buy at Citi. 2. Latham Group (SWIM) initiated with an Outperform at William Blair, Baird and Wolfe Research, initiated with an Overweight at KeyBanc and Barclays, initiated with a Neutral at Goldman Sachs and initiated with an Equal Weight at Morgan Stanley. 3. Pool Corp. (POOL) initiated with a Buy at Goldman Sachs. 4. BioNTech (BNTX) initiated with a Neutral at Goldman Sachs. 5. Agiliti (AGTI) initiated with a Buy at Goldman Sachs, BofA, Jefferies, and Citi, initiated with an Overweight at Morgan Stanley and KeyBanc, initiated with an Outperform at BMO Capital and Raymond James, and initiated with a Neutral at UBS. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
RAIN Rain Therapeutics
$16.72 /

+0.415 (+2.55%)

POOL Pool Corp.
$436.99 /

+0.98 (+0.22%)

BNTX BioNTech
$193.16 /

-5.01 (-2.53%)

RAIN Rain Therapeutics
$16.72 /

+0.415 (+2.55%)

06:23 Today Citi
Rain Therapeutics initiated with a Buy at Citi
06:20 Today Guggenheim
Rain Therapeutics initiated with a Buy at Guggenheim
04:52 Today Goldman Sachs
Rain Therapeutics initiated with a Buy at Goldman Sachs
04:49 Today Piper Sandler
Rain Therapeutics initiated with an Overweight at Piper Sandler
SWIM Latham Group
$33.08 /

+0.39 (+1.19%)

07:29 Today KeyBanc
KeyBanc bullish on Latham Group, initiates with an Overweight
07:20 Today Truist
Truist starts 'secular growth story' Latham Group at Buy
07:11 Today Baird
Latham Group to solidify fiberglass lead, Baird starts with Outperform
07:06 Today William Blair
William Blair starts 'dominant' manufacturer Latham with Outperform
POOL Pool Corp.
$436.99 /

+0.98 (+0.22%)

05:00 Today Goldman Sachs
Pool Corp. initiated with a Buy at Goldman Sachs
04/23/21 Loop Capital
Pool Corp. price target raised to $440 from $405 at Loop Capital
04/23/21 Baird
Pool Corp. price target raised to $444 from $360 at Baird
04/20/21 Loop Capital
Pool Corp. price target raised to $405 from $390 at Loop Capital
BNTX BioNTech
$193.16 /

-5.01 (-2.53%)

05:49 Today Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
05/11/21 SVB Leerink
BioNTech price target raised to $159 from $118 at SVB Leerink
AGTI Agiliti
$15.04 /

+0.28 (+1.90%)

08:10 Today Jefferies
Jefferies starts medical equipment outsourcing 'pioneer' Agiliti at Buy
07:31 Today KeyBanc
KeyBanc bullish on Agiliti, initiates with an Overweight
07:24 Today UBS
Agiliti initiated with a Neutral at UBS
07:16 Today Raymond James
Agiliti initiated with an Outperform at Raymond James
POOL Pool Corp.
$436.99 /

+0.98 (+0.22%)

BNTX BioNTech
$193.16 /

-5.01 (-2.53%)

  • 23
    Apr
  • 23
    Apr
  • 23
    Apr
  • 23
    Jul
POOL Pool Corp.
$436.99 /

+0.98 (+0.22%)

BNTX BioNTech
$193.16 /

-5.01 (-2.53%)

SWIM Latham Group
$33.08 /

+0.39 (+1.19%)

RAIN Rain Therapeutics
$16.72 /

+0.415 (+2.55%)

BNTX BioNTech
$193.16 /

-5.01 (-2.53%)

POOL Pool Corp.
$436.99 /

+0.98 (+0.22%)

BNTX BioNTech
$193.16 /

-5.01 (-2.53%)

Initiation
Jefferies starts medical equipment outsourcing 'pioneer' Agiliti at Buy » 08:10
05/18/21
05/18
08:10
05/18/21
08:10
AGTI

Agiliti

$14.74 /

+1.05 (+7.67%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGTI Agiliti
$14.74 /

+1.05 (+7.67%)

07:31 Today KeyBanc
KeyBanc bullish on Agiliti, initiates with an Overweight
07:24 Today UBS
Agiliti initiated with a Neutral at UBS
07:16 Today Raymond James
Agiliti initiated with an Outperform at Raymond James
06:45 Today Morgan Stanley
Morgan Stanley starts 'uniquely positioned' Agiliti at Overweight
  • 23
    Apr
Initiation
KeyBanc bullish on Agiliti, initiates with an Overweight » 07:31
05/18/21
05/18
07:31
05/18/21
07:31
AGTI

Agiliti

$14.74 /

+1.05 (+7.67%)

As previously reported,…

As previously reported, KeyBanc analyst Matthew Mishan initiated coverage of Agiliti with an Overweight rating and $21 price target. The analyst believes Agiliti is building an attractive long-term growth model that is increasing the penetration of outsourced services through a scaled platform and a more defined value proposition to healthcare systems. More specifically, it has an unmatched national service footprint and addresses customer needs; there is long-term visibility to HSD growth potential based on entering new adjacencies, while expanding TAM and customer share of wallet; it's solidly profitable, but COVID-19 created some near-term comparison issues; the leverage profile appears reasonable with room for M&A; and current valuation doesn't reflect its long-term growth potential, Mishan contends.

ShowHide Related Items >><<
AGTI Agiliti
$14.74 /

+1.05 (+7.67%)

07:24 Today UBS
Agiliti initiated with a Neutral at UBS
07:16 Today Raymond James
Agiliti initiated with an Outperform at Raymond James
06:45 Today Morgan Stanley
Morgan Stanley starts 'uniquely positioned' Agiliti at Overweight
06:31 Today Citi
Agiliti initiated with a Buy at Citi
  • 23
    Apr
Initiation
Agiliti initiated with a Neutral at UBS » 07:24
05/18/21
05/18
07:24
05/18/21
07:24
AGTI

Agiliti

$14.74 /

+1.05 (+7.67%)

UBS analyst Kevin…

UBS analyst Kevin Caliendo initiated coverage of Agiliti with a Neutral rating and $16 price target. The analyst notes the balance between an opportunity around hospital outsourcing, the company's attractive fundamentals, and its cross-selling potential with risks around execution and competition.

ShowHide Related Items >><<
AGTI Agiliti
$14.74 /

+1.05 (+7.67%)

07:16 Today Raymond James
Agiliti initiated with an Outperform at Raymond James
06:45 Today Morgan Stanley
Morgan Stanley starts 'uniquely positioned' Agiliti at Overweight
06:31 Today Citi
Agiliti initiated with a Buy at Citi
06:11 Today Jefferies
Agiliti initiated with a Buy at Jefferies
  • 23
    Apr
Initiation
Agiliti initiated with an Outperform at Raymond James » 07:16
05/18/21
05/18
07:16
05/18/21
07:16
AGTI

Agiliti

$14.74 /

+1.05 (+7.67%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGTI Agiliti
$14.74 /

+1.05 (+7.67%)

06:45 Today Morgan Stanley
Morgan Stanley starts 'uniquely positioned' Agiliti at Overweight
06:31 Today Citi
Agiliti initiated with a Buy at Citi
06:11 Today Jefferies
Agiliti initiated with a Buy at Jefferies
06:06 Today BofA
Agiliti initiated with a Buy at BofA
  • 23
    Apr
Initiation
Morgan Stanley starts 'uniquely positioned' Agiliti at Overweight » 06:45
05/18/21
05/18
06:45
05/18/21
06:45
AGTI

Agiliti

$14.74 /

+1.05 (+7.67%)

As previously reported,…

As previously reported, Morgan Stanley analyst Drew Ranieri initiated coverage of Agiliti with an Overweight rating and $21 price target. With its comprehensive outsourcing service offerings, "unrivaled footprint," and growing suite of offerings, Agiliti is "uniquely positioned to address the pain points of healthcare providers" with a service model thathelps reduce the cost and complexity of acquiring, managing, and maintaining critical medical equipment, Ranieri tells investors. In addition, shares have traded down about 17% since the company's IPO, which Ranieri sees improving the risk/reward.

ShowHide Related Items >><<
AGTI Agiliti
$14.74 /

+1.05 (+7.67%)

06:31 Today Citi
Agiliti initiated with a Buy at Citi
06:11 Today Jefferies
Agiliti initiated with a Buy at Jefferies
06:06 Today BofA
Agiliti initiated with a Buy at BofA
06:00 Today KeyBanc
Agiliti initiated with an Overweight at KeyBanc
  • 23
    Apr
Initiation
Agiliti initiated with a Buy at Citi » 06:31
05/18/21
05/18
06:31
05/18/21
06:31
AGTI

Agiliti

$14.74 /

+1.05 (+7.67%)

Citi analyst Ralph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGTI Agiliti
$14.74 /

+1.05 (+7.67%)

06:11 Today Jefferies
Agiliti initiated with a Buy at Jefferies
06:06 Today BofA
Agiliti initiated with a Buy at BofA
06:00 Today KeyBanc
Agiliti initiated with an Overweight at KeyBanc
05:59 Today Morgan Stanley
Agiliti initiated with an Overweight at Morgan Stanley
  • 23
    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.